全文获取类型
收费全文 | 48351篇 |
免费 | 3239篇 |
国内免费 | 909篇 |
专业分类
耳鼻咽喉 | 366篇 |
儿科学 | 1235篇 |
妇产科学 | 1274篇 |
基础医学 | 5408篇 |
口腔科学 | 864篇 |
临床医学 | 4103篇 |
内科学 | 11460篇 |
皮肤病学 | 782篇 |
神经病学 | 4480篇 |
特种医学 | 1801篇 |
外国民族医学 | 2篇 |
外科学 | 6697篇 |
综合类 | 2083篇 |
现状与发展 | 1篇 |
一般理论 | 2篇 |
预防医学 | 2435篇 |
眼科学 | 595篇 |
药学 | 4107篇 |
8篇 | |
中国医学 | 965篇 |
肿瘤学 | 3831篇 |
出版年
2023年 | 392篇 |
2022年 | 626篇 |
2021年 | 1536篇 |
2020年 | 1066篇 |
2019年 | 1179篇 |
2018年 | 1349篇 |
2017年 | 1088篇 |
2016年 | 1146篇 |
2015年 | 1464篇 |
2014年 | 1916篇 |
2013年 | 2396篇 |
2012年 | 3107篇 |
2011年 | 3162篇 |
2010年 | 1914篇 |
2009年 | 1724篇 |
2008年 | 2701篇 |
2007年 | 2708篇 |
2006年 | 2502篇 |
2005年 | 2381篇 |
2004年 | 2163篇 |
2003年 | 1867篇 |
2002年 | 1689篇 |
2001年 | 1440篇 |
2000年 | 1353篇 |
1999年 | 1244篇 |
1998年 | 436篇 |
1997年 | 324篇 |
1996年 | 341篇 |
1995年 | 293篇 |
1994年 | 271篇 |
1993年 | 229篇 |
1992年 | 693篇 |
1991年 | 588篇 |
1990年 | 557篇 |
1989年 | 563篇 |
1988年 | 474篇 |
1987年 | 438篇 |
1986年 | 408篇 |
1985年 | 328篇 |
1984年 | 266篇 |
1983年 | 214篇 |
1982年 | 122篇 |
1979年 | 214篇 |
1978年 | 130篇 |
1977年 | 112篇 |
1974年 | 122篇 |
1973年 | 127篇 |
1972年 | 124篇 |
1971年 | 113篇 |
1969年 | 104篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Ashley Di Meo Ihor Batruch Marshall D. Brown Chuance Yang Antonio Finelli Michael A. Jewett Eleftherios P. Diamandis George M. Yousef 《International journal of cancer. Journal international du cancer》2020,146(8):2315-2325
Renal cell carcinoma (RCC) is frequently diagnosed incidentally as an early-stage small renal mass (SRM; pT1a, ≤4 cm). Overtreatment of patients with benign or clinically indolent SRMs is increasingly common and has resulted in a recent shift in treatment recommendations. There are currently no available biomarkers that can accurately predict clinical behavior. Therefore, we set out to identify early biomarkers of RCC progression. We employed a quantitative label-free liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) proteomics approach and targeted parallel-reaction monitoring to identify and validate early, noninvasive urinary biomarkers for RCC-SRMs. In total, we evaluated 115 urine samples, including 33 renal oncocytoma (≤4 cm) cases, 30 progressive and 26 nonprogressive clear cell RCC (ccRCC)-SRM cases, in addition to 26 healthy controls. We identified six proteins, which displayed significantly elevated expression in clear cell RCC-SRMs (ccRCC-SRMs) relative to healthy controls. Proteins C12ORF49 and EHD4 showed significantly elevated expression in ccRCC-SRMs compared to renal oncocytoma (≤4 cm). Additionally, proteins EPS8L2, CHMP2A, PDCD6IP, CNDP2 and CEACAM1 displayed significantly elevated expression in progressive relative to nonprogressive ccRCC-SRMs. A two-protein signature (EPS8L2 and CCT6A) showed significant discriminatory ability (areas under the curve: 0.81, 95% CI: 0.70–0.93) in distinguishing progressive from nonprogressive ccRCC-SRMs. Patients (Stage I–IV) with EPS8L2 and CCT6A mRNA alterations showed significantly shorter overall survival (p = 1.407 × 10−6) compared to patients with no alterations. Our in-depth proteomic analysis identified novel biomarkers for early-stage RCC-SRMs. Pretreatment characterization of urinary proteins may provide insight into early RCC progression and could potentially help assign patients to appropriate management strategies. 相似文献
42.
Annalisa Guida Gwnaël Le Teuff Carolina Alves Emeline Colomba Vincenzo Di Nunno Lisa Derosa Ronan Flippot Bernard Escudier Laurence Albiges 《Oncotarget》2020,11(49):4582
Majority of patients with clear-cell renal cell carcinoma (ccRCC) at first line (1L) treatment are classified in the intermediate-risk (IR) subgroup according to International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) score. As these patients have different prognosis, the aim of this study is to better characterize IR patients in order to better tailor the treatment. Retrospective analysis was performed from IGReCC (Institut Gustave Roussy Renal Cell Carcinoma) database. Overall survival (OS) was defined from start of 1L therapy to death or last follow-up. A multivariable Cox model with backward selection procedure (α = 0.01) and a Classification and Regression Tree (CART) analysis were performed to identify which prognostic factors were associated to OS in IR patients.From 2005 to 2017, 777 patients with ccRCC were treated with an anti-VEGF 1L therapy. Among 571 evaluable patients for IMDC score, 290 (51%) were classified as IR. With median follow-up 5.8 years (min: 0, max: 12.4) 212 deaths (73%) were observed and median OS was 25 months. Only platelet count was significantly associated to OS (hazard ratio 1.88 [95% CI 1.27–2.88] p = 0.0017). Median OS for patients with PLT > UNL was 18 months [95% CI 12–23] versus 29 months [95% CI 21.4–35.7] for patients with normal PLT count. The selection of PLT count was confirmed on bootstrap samples and was also selected for the first split of the CART-tree analysis.Patients in the IR group have a heterogeneous prognosis. Elevated PLT count seems identifies a subgroup of patients with poor outcome in the IMDC intermediate-risk population with ccRCC. 相似文献
43.
44.
45.
Ferdinando Carlo Sasso Pia Clara Pafundi Alfredo Caturano Raffaele Galiero Erica Vetrano Riccardo Nevola Salvatore Petta Anna Ludovica Fracanzani Carmine Coppola Vito Di Marco Antonio Solano Rosa Lombardi Mauro Giordano Antonio Craxi Alessandro Perrella Celestino Sardu Raffaele Marfella Teresa Salvatore Luca Rinaldi 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2021,31(8):2345-2353
Background and aimsBeyond type 2 diabetes, even a condition of prediabetes is associated with an increased cardiovascular (CV) risk, and HCV infection coexistence represents an exacerbating factor. CV prognosis improvement in prediabetes represents a challenge, due to the increasing prevalence of this metabolic condition worldwide. Hence, we aimed to prospectively assess how direct acting antivirals (DAAs) could affect major cardiovascular events (MACE) in a prediabetic HCV positive cohort.Methods and resultsIn this prospective multicenter study, we enrolled HCV patients with overt prediabetes. We compared a subgroup of patients treated with DAAs with untreated prediabetic controls. We recorded all CV events occurred during an overall median follow-up of 24 months (IQR 19–34). 770 HCV positive prediabetic patients were enrolled, 398 untreated controls and 372 DAAs treated patients. Overall, the CV events annual incidence was much higher among prediabetic treated patients (1.77 vs. 0.62, p < 0.001), and HCV clearance demonstrated to significantly reduce CV events (RR: 0.411, 95%CI 0.148–1.143; p < 0.001), with an estimated NNT for one additional patient to benefit of 52.1. Moreover, an independent association between a lower rate of CV events and HCV clearance after DAAs was observed (OR 4.67; 95%CI 0.44–53.95; p = 0.016).ConclusionsHCV eradication by DAAs allows a significant reduction of MACEs in the prediabetic population, and therefore represents a primary objective, regardless of the severity of liver disease and CV risk factors. 相似文献
46.
Giuseppina Natale MSc Annabella Pignataro PhD Gioia Marino MSc Federica Campanelli PhD Valeria Calabrese MSc Antonella Cardinale PhD Silvia Pelucchi PhD Elena Marcello PhD Fabrizio Gardoni PhD Maria Teresa Viscomi PhD Barbara Picconi PhD Martine Ammassari-Teule PhD Paolo Calabresi MD Veronica Ghiglieri PhD 《Movement disorders》2021,36(10):2254-2263
47.
48.
49.
Zihao Yu Di Kong Jiajun Peng Zehao Wang Yongjie Chen 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2021,31(1):52-59
Background and aimsFew studies have explored the association between malnutrition, defined by the Geriatric Nutritional Risk Index (GNRI), and all-cause mortality, particularly in the Chinese population. This study aimed to investigate the association between the GNRI and all-cause mortality in the elderly population.Methods and resultsParticipants aged ≥60 years were eligible for this study and were divided into three groups by the GNRI: An adequate nutrition group, participants with a GNRI ≥98; mild malnutrition group, participants with a GNRI ≥82 but <98; and a severe malnutrition group, participants with a GNRI <82. The results implied that there was a positive association between severe malnutrition and all-cause mortality in the total population (hazard ratio (HR): 2.591 and 95% confidence interval (CI): 1.729–3.884), male subjects (HR: 2.903 and 95% CI: 1.718–4.906), and female subjects (HR: 2.081 and 95% CI: 1.071–4.046). Similar associations between severe malnutrition and all-cause mortality were observed in both the 60–69 and 70–79 years age groups (HR: 2.863 and 2.600, 95% CI: 1.444–5.678 and 1.394–4.849, respectively). However, no significant association was observed between mild malnutrition and all-cause mortality.ConclusionsSevere malnutrition could increase all-cause mortality in the 60- to 79-year-old population. However, there was no association of mild malnutrition with all-cause mortality. 相似文献
50.
Yawei Wang Di Chen Yu Liu Yong Zhang Chao Duan Wuxiyar Otkur Huan Chen Xiaolong Liu Tian Xia Huan Qi Hai-long Piao Hong-Xu Liu 《Cancer science》2021,112(8):3278-3292
It is widely accepted that redox reprogramming participates in malignant transformation of lung adenocarcinoma (LUAD). However, the source of excessive reactive oxygen species (ROS) and the downstream signaling regulatory mechanism are complicated and unintelligible. In the current study, we newly identified the aquaporin 3 (AQP3) as a LUAD oncogenic factor with capacity to transport exogenous hydrogen peroxide (H2O2) and increase intracellular ROS levels. Subsequently, we demonstrated that AQP3 was necessary for the facilitated diffusion of exogenous H2O2 in LUAD cells and that the AQP3-dependent transport of H2O2 accelerated cell growth and inhibited rapamycin-induced autophagy. Mechanistically, AQP3-mediated H2O2 uptake increased intracellular ROS levels to inactivate PTEN and activate the AKT/mTOR pathway to subsequently inhibit autophagy and promote proliferation in LUAD cells. Finally, we suggested that AQP3 depletion retarded subcutaneous tumorigenesis in vivo and simultaneously decreased ROS levels and promoted autophagy. These findings underscore the importance of AQP3-induced oxidative stress in malignant transformation and suggest a therapeutic target for LUAD. 相似文献